Gene Query: FUT4

Dataset Description Geneva Score
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 73.58
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 73.58
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 68.55
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 68.55
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 40.57
Effects of rFVIIIFc on human macrophages 34.36
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 34.17
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 33.66
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 28.84
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 26.51
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 26.05
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 25.94
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 25.94
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 25.45
Transcriptome analysis of SKI knock-out in HL60 cells 25.45
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 25.43
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 24.7
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 24.64
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 24.24
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 24.24
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 22.99
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 22.31
Gene expression changes associated with resistance to tagraxofusp (SL-401) 18.73
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 18.45
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 18.33
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 18.28
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 18.28
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 17.93
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 17.39
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 15.07
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 14.27
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 14.1
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 13.69
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 13.46
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 13.34
HNF1 regulates critical functions of the human epididymis epithelium. 13.18
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 13.18
Intron retention induced by microsatellite expansions as a disease biomarker. 13.02
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 12.44
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 11.64
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 11.63
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 11.56
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 11.34
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 10.94
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 10.83
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 10.81
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 10.81
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 10.29
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 9.89
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 9.71
The pioneer factor CEBPA modulates vitamin D signaling 9.49
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 9.49
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 9.47
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 9.27
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 8.95
Transcriptomes of oxLDL exposed trained monocytes 8.84
oxLDL exposed trained monocytes 8.84
EP400 is required for Max and MCPyV mediated gene activation 8.79
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 8.74
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 8.74
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 8.61
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 8.61
Identifying the molecular mode of action of itraconazole in colorectal cancer 8.61
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 8.46
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 8.46
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 8.36
Pharmacologic inhibition of STAT5 in AML 8.17
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 8.06
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 8.06
CircRNAome diversity in human mature B-cells, T-cells and monocytes 7.97
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 7.79
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.75
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.75
RNA-Seq in neutrophils from Antiphospholipid Syndrome 7.72
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.62
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 7.46
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 7.34
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.31
Altering cancer transcriptomes using epigenomic inhibitors 7.18
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 7.18
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 7.14
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 7.08
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 7.05
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 7.05
A map of gene expression in neutrophil-like cell lines 6.88
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 6.79
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 6.79
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.77
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 6.72
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 6.69
MicroRNA-125a-5p overexpression in human macrophages 6.68
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 6.53
Transcriptome of EBV-infected gastric cancer cell lines 6.51
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.48
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 6.47
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 6.35
Generation and functional characterization of MDSC-like cells 6.3
The role of the Calcium-Sensing receptor in colorectal cancer 6.19
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 6.19
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.12
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.1
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 6.08
Macrophage Ad5f35 M2 Challenge 6.07
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.0
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 6.0
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 5.95
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 5.95
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 5.77
Noncoding regions are the main source of targetable tumor-specific antigens 5.72
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.72
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 5.7
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.56
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 5.55
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 5.53
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 5.38
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 5.38
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 5.35
HEXIM1 is induced by DHODH inhibition to suppress melanoma 5.35
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.29
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 5.29
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 5.26
TAF1 is critical for AE driven leukemogenesis 5.26
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 5.26
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.24
Identification of long noncoding RNAs regulated by p53 5.24
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.23
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 5.21
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.12
Primate transcript and protein expression levels evolve under compensatory selection pressures 5.02
RNA expression analysis upon JMJD1C depletion 5.01
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.01
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.99
Depicting early human development and germ cell origin with porcine embryos 4.99
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 4.96
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.78
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.76
NAPRT activation of macrophages 4.76
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.73
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.71
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 4.63
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 4.63
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 4.5
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.5
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.41
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 4.37
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 4.34
RNA-Seq from early time points in the kidney differentiation protocol 4.33
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.32
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 4.31
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 4.29
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 4.29
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.28
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.27
MEIS1 regulates hematopoiesis in hPSCs 4.26
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 4.26
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 4.26
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 4.25
Transcriptome-wide identification of CELF2 functional targets in T cells 4.24
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 4.23
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 4.23
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 4.18
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.11
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 4.08
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 4.07
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 4.07
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.07
Total RNA sequencing of APC mutant and wt colonic organoids 4.02
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 3.94
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 3.93
MYCL and EP400 are required for Max and MCPyV mediated gene activation 3.85
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 3.83
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.82
Macrophage Ad5f35 PhenoMap 3.71
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 3.69
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 3.69
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.68
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 3.67
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.67
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 3.66
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 3.62
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 3.6
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 3.47
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 3.47
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.46
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 3.43
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 3.39
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 3.39
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 3.34
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.33
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.33
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 3.31
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 3.29
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 3.23
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 3.23
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.17
RNA-Seq analysis of breast cancer cells after shikonin treatment 3.17
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.14
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.14
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.08
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 3.08
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 3.08
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.04
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.03
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.98
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 2.95
Human embryonic stem cells in E8 and AKIT culture medium 2.95
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.94
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.94
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.93
JAK dependent survival of ALK- ALCL 2.91
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.9
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 2.9
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.86
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 2.86
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 2.86
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 2.86
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 2.85
Targeted enhancer activation by a subunit of the integrator complex 2.85
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.83
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.83
Direct Isolation and Characterization of Human Nephron Progenitors. 2.81
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.79
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 2.76
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.75
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.75
TCF7L1 knockdown in pancreatic cancer 2.74
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.73
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.72
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.72
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.7
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.7
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.66
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.66
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 2.65
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 2.63
Transcription elongation regulates genome 3D structure 2.62
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 2.6
Dysregulated immune system networks in war veterans with PTSD 2.59
ARID1A regulates condensin II distribution and chromosomal partition 2.59
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 2.59
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.58
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 2.56
Bone marrow derived human B cells [normal proB] 2.56
The evolution of N6-methyladenosine in primates 2.56
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.53
Ro60-knockout cells 2.52
WRN knockout effects upon gene expression in SW48 and OVK18 2.51
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 2.45
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.43
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 2.39
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 2.39
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.38
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.36
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.36
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 2.36
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.33
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.32
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 2.32
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 2.32
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.31
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 2.31
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 2.31
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.29
RNA-seq of CD33 KO and control HSPCs 2.27
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.27
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.25
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 2.24
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.23
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.22
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 2.22
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 2.22
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 2.21
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.2
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.2
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.2
PRDM1 inhibits proliferation of human colon cancer organoids 2.2
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 2.17
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 2.17
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.13
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.12
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.1
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.09
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.06
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.05
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.05
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.03
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 2.03
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.02
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 2.0
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.0
Functional significance of the HIV-1 Tat signature amino acid residues 2.0
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 1.98
Peptidomimetic blockade of MYB in acute myeloid leukemia 1.98
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.97
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.97
RNA-seq of YB5 cells treated with Proscillaridin A 1.97
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.95
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.95
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 1.93
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.92
MARCKS and lnc-MARCKS act as inflammation regulators 1.91
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 1.9
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.89
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.89
Targeting MTHFD2 in Acute Myeloid Leukemia 1.88
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.87
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.87
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.86
CD95/Fas ligand mRNA is toxic to cells 1.86
Tpl-2 and MEK small molecule inhibitors 1.85
Tpl-2 small molecule project 1.85
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 1.84
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.84
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.82
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 1.81
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.8
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 1.8
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 1.79
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 1.79
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 1.79
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.76
Specific molecular signatures underlie response to decitabine in CMML 1.73
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.73
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 1.71
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 1.7
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 1.7
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.7
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 1.7
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 1.7
Gene expression alterations of pancreatic intraepithlial neoplasia 1.69
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.69
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.68
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.68
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 1.68
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.67
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.63
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.62
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.61
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.61
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 1.57
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.53
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.53
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 1.52
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 1.5
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 1.5
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.5
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.5
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.49
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 1.48
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 1.48
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.47
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.46
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.45
Leucegene: ALL sequencing 1.44
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.44
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.39
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 1.38
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 1.38
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.35
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.32
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.28
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.25
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.23
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.21
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.21
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.21
Irf9 function in immunity in mouse 1.19
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 1.19
Expression profiles of the four human major ectodermal lineages 1.16
RNA-seq of primary patient AML samples 1.16
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.14
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.13
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.13
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.12
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.1
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.1
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 1.07
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.07
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.03
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 1.02
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.01
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.01
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 1.0
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.99
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.97
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 0.96
RNA-seq of cancer cell lines treated with T-025 0.96
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.95
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.94
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.92
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.9
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.9
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.89
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.88
Human ovarian granulosa cell transcriptome 0.87
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.87
Clinker: visualizing fusion genes detected in RNA-seq data 0.85
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.82
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.82
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 0.82
Human islets of varying quality: the good, the (not so) bad and the ugly 0.82
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.79
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.79
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.78
The gene expression profiles of gallbladder cancer 0.77
Transcriptional profile in human S. haematobium infection 0.76
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.72
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.72
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.72
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.71
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.7
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.7
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.7
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.7
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 0.69
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.69
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.68
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.68
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.68
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.66
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.66
RNA sequencing of human pancreatic cancer cell lines 0.63
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 0.6
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 0.57
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 0.57
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.56
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.56
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.54
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.54
Leucegene: AML sequencing (part 6) 0.54
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.52
quanTIseq: quantifying immune contexture of human tumors 0.52
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.52
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.52
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.51
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.51
The expression profiles of GBC liver metastasis 0.49
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.49
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.48
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.46
RNA seq analysis of human Fetal and adult derived Enterospheres 0.46
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.46
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.44
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.43
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.42
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.42
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.39
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.39
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.39
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.38
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.38
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.37
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.37
MHC Transcriptomic landscape at haplotype-specific resolution 0.36
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.36
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.35
Transcriptome analysis of peripheral blood monocytes 0.34
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.34
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.34
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.33
Gene expression analysis of human adenomas. 0.32
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 0.32
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.32
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.32
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.3
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.3
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.29
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.29
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.28
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.28
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.22
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.22
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.21
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.2
RNA sequencing of T-ALL (COG study) 0.2
Analyses of T-ALL (COG study) 0.2
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.17
KSDM1b Role in Ewing Sarcoma 0.15
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.15
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.14
Transcriptome Profiling of Human Primary Monocytes 0.14
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.13
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.13
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.13
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.09
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.09
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.08
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.08
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.07
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.07
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.06
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 0.06
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.06
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.04
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.03
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.03
Transcriptomic analysis of human macrophages in 3D 0.01
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation